456 results on '"van Erven, Lieselot"'
Search Results
2. Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients: a position statement by the Task Force of the Dutch Society of Cardiology
3. NL-EVDR: Netherlands—ExtraVascular Device Registry
4. Remarkably high and accelerating failure rate of a widely used implantable cardioverter-defibrillator lead: a large-scale manufacturer-independent multicenter study with long accurate follow-up
5. Five-year safety and efficacy of leadless pacemakers in a Dutch cohort
6. Stop de icd
7. One-Year Mortality in Patients Undergoing an Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy Pulse Generator Replacement: Identifying Patients at Risk
8. Nationwide Longitudinal Follow-Up of Riata Leads Under Advisory at 3 Annual Screenings: Report From the Netherlands Heart Rhythm Association Device Advisory Committee
9. Long-Term Echocardiographic Outcome in Super-Responders to Cardiac Resynchronization Therapy and the Association With Mortality and Defibrillator Therapy
10. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients: The Prospective, Randomized, Controlled ICD2 Trial
11. The development of a decision aid for shared decision making in the Dutch implantable cardioverter defibrillator patient population: A novel approach to patient education
12. Cardiac resynchronization therapy in adults with congenital heart disease
13. Complex Issues in the Follow-up of CRT Devices
14. Complications of pacemaker therapy in adults with congenital heart disease: A multicenter study
15. Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment
16. Implantable cardioverter-defibrillators and the older patient: the Dutch clinical practice
17. Development of Central Venous Stenosis Upon ICD Implantation in Dialysis Patients: A Non-Negligible Issue
18. Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices: A Systematic Review of Randomized Clinical Trials
19. Prognostic Impact of Implementation of QRS Characteristics in the Seattle Heart Failure Model in ICD and CRT-D Recipients
20. How adequate are the current methods of lead extraction? A review of the efficiency and safety of transvenous lead extraction methods
21. EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring
22. Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy
23. Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment
24. Failing systemic right ventricle in a patient with dextrocardia and complex congenitally corrected transposition of the great arteries: a case report of successful transvenous cardiac resynchronization therapy
25. Chronic Kidney Disease and Implantable Cardioverter Defibrillator Related Complications: 16 Years of Experience
26. Primary prevention implantable cardioverter-defibrillator implantation in elderly patients: is it justified to withhold treatment?
27. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the Wireless Stimulation Endocardially for CRT (WiSE-CRT) study
28. Cost-Effectiveness of Primary Prevention Implantable Cardioverter Defibrillator Treatment: Data from a Large Clinical Registry
29. Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death
30. Atrial-based pacing has no benefit over ventricular pacing in preventing atrial arrhythmias in adults with congenital heart disease
31. Intrathoracic Impedance Monitoring to Predict Decompensated Heart Failure
32. Quantification of left ventricular mechanical dyssynchrony by conductance catheter in heart failure patients
33. Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients
34. Impact of clinical and echocardiographic response to cardiac resynchronization therapy on long-term survival
35. Suitability for subcutaneous defibrillator implantation: results based on data from routine clinical practice
36. Right ventricular function and survival following cardiac resynchronisation therapy
37. Influence of Diabetes on Left Ventricular Systolic and Diastolic Function and on Long-Term Outcome After Cardiac Resynchronization Therapy
38. Right Ventricular Pacing Can Induce Ventricular Dyssynchrony in Patients With Atrial Fibrillation After Atrioventricular Node Ablation
39. Benefit of Combined Resynchronization and Defibrillator Therapy in Heart Failure Patients With and Without Ventricular Arrhythmias
40. Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients
41. Predictors of long-term benefit of cardiac resynchronization therapy in patients with right bundle branch block
42. Update on Small-Diameter Implantable Cardioverter-Defibrillator Leads Performance
43. Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score
44. Effect of cardiac resynchronization therapy in patients without left intraventricular dyssynchrony
45. Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey
46. Trans-venous lead removal without the use of extraction sheaths, results of >250 removal procedures
47. Prophylactic implantable cardioverter–defibrillator treatment in the elderly: therapy, adverse events, and survival gain
48. Primary Prevention Implantable Cardioverter Defibrillator Recipients: The Need for Defibrillator Back-Up After an Event-Free First Battery Service-Life
49. Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach
50. The effect of cardiac resynchronization therapy on left ventricular diastolic function assessed with speckle-tracking echocardiography
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.